Evidence map›Paper›PMID 26047718›Full record

ArticleJournal of proteomics2015

Benchmark study of automatic annotation of MALDI-TOF N-glycan profiles.

Alejandro E Brito, Doron Kletter, Mudita Singhal, Marshall Bern

Abstract readComparative StudyEvaluation StudyValidation Study
In one paragraph

Article in Journal of proteomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. High-Throughput Glycomic Methods.Chemical reviews · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alejandro E BritoPalo Alto Research Center, USA.
Doron KletterProtein Metrics Inc., USA.
Mudita SinghalPalo Alto Research Center, USA.
Marshall BernProtein Metrics Inc., USA. Electronic address: bern@proteinmetrics.com.

Funding

Widely Distributed Software for Using Mass Spectrometry to Identify GlycansR01GM103428 · NIGMS · PALO ALTO RESEARCH CENTER · PI BERN, MARSHALL WAYNE · 2012 to 2013
$799k
Algorithms and Software for Difficult Proteomics ProblemsR21GM085718 · NIGMS · PALO ALTO RESEARCH CENTER · PI BERN, MARSHALL WAYNE · 2008 to 2009
$750k
NIGMS NIH HHS R01GM085718NIGMS NIH HHS R01 GM103428NIGMS NIH HHS R21 GM085718
6 · The paper itself

Abstract

Human experts can annotate peaks in MALDI-TOF profiles of detached N-glycans with some degree of accuracy. Even though MALDI-TOF profiles give only intact masses without any fragmentation information, expert knowledge of the most common glycans and biosynthetic pathways in the biological system can point to a small set of most likely glycan structures at the "cartoon" level of detail. Cartoonist is a recently developed, fully automatic annotation tool for MALDI-TOF glycan profiles. Here we benchmark Cartoonist's automatic annotations against human expert annotations on human and mouse N-glycan data from the Consortium for Functional Glycomics. We find that Cartoonist and expert annotations largely agree, but the expert tends to annotate more specifically, meaning fewer suggested structures per peak, and Cartoonist more comprehensively, meaning more annotated peaks. On peaks for which both Cartoonist and the expert give unique cartoons, the two cartoons agree in over 90% of all cases. This article is part of a Special Issue entitled: Computational Proteomics.

Indexed as

AlgorithmsSoftwareBenchmarkingCarbohydrate SequenceHumansMolecular Sequence DataPattern Recognition, AutomatedPolysaccharidesReproducibility of ResultsSensitivity and SpecificitySequence AnalysisSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationPolysaccharidesBioinformaticsGlycomicsGlycosylationMass spectrometry

Identifiers

PMID26047718
PMCPMC4630163

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.